Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Post by Greencashon Jun 15, 2018 9:44am
42 Views
Post# 28177014

Canadian insurer introducing medical cannabis product

Canadian insurer introducing medical cannabis product
123RF.com/Alexander Korzh

 

 

Markers Financial Inc. is launching a group insurance product that covers medical cannabis on Aug. 15.

The company, which is a division of Toronto-based Evergreen Pacific Insurance Corp., will initially roll out an insurance product for individuals, tailored to each person’s requirements without any caps or restrictions based on pre-existing conditions.

Read: Reformulary Group to develop cannabis formulary

It has started enrolling licensed cannabis producers as suppliers, as well as channel sales partners across Canada. Markers will pay producers directly, allowing for no out-of-pocket costs for individual users or plan members.

“Our introduction of insurance coverage for medical cannabis will go a long way toward supporting a more legitimate, patient-centric approach to patient care in Canada,” said Robert Wilson, chief executive officer of Evergreen, in a news release. “We anticipate a very positive market reception in August.”


Bullboard Posts